Reata Pharmaceuticals, Inc. - (RETA) Social Stream

Featured Post From StockTwits About RETA

$RETA >> BUY THE DIP >>>

"The FDA has not listed any safety issues as significant issues. Additionally, FDA does not believe a Risk Evaluation and Mitigation Strategies (“REMS”) program is needed. The FDA also informed Reata that an Advisory Committee meeting is tentatively scheduled for Dec 8."

It's all good 👍 >> they actually had a positive earnings surprise >>

This is a dip load opportunity >>

Got calls! $$$$$